JPS6126914B2 - - Google Patents
Info
- Publication number
- JPS6126914B2 JPS6126914B2 JP54041274A JP4127479A JPS6126914B2 JP S6126914 B2 JPS6126914 B2 JP S6126914B2 JP 54041274 A JP54041274 A JP 54041274A JP 4127479 A JP4127479 A JP 4127479A JP S6126914 B2 JPS6126914 B2 JP S6126914B2
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- antibiotic
- absorption
- culture
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 230000003115 biocidal effect Effects 0.000 claims description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- 238000010521 absorption reaction Methods 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000000862 absorption spectrum Methods 0.000 claims description 5
- 150000002337 glycosamines Chemical class 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 claims description 3
- 231100000252 nontoxic Toxicity 0.000 claims description 3
- 230000003000 nontoxic effect Effects 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 238000004042 decolorization Methods 0.000 claims description 2
- 238000000921 elemental analysis Methods 0.000 claims description 2
- 238000001819 mass spectrum Methods 0.000 claims description 2
- 238000005259 measurement Methods 0.000 claims description 2
- 238000002844 melting Methods 0.000 claims description 2
- 230000008018 melting Effects 0.000 claims description 2
- 239000012286 potassium permanganate Substances 0.000 claims description 2
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 claims 1
- 239000002609 medium Substances 0.000 description 16
- 229920001817 Agar Polymers 0.000 description 7
- 239000008272 agar Substances 0.000 description 7
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 235000011114 ammonium hydroxide Nutrition 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- -1 amino sugar compound Chemical class 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 210000003495 flagella Anatomy 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000001362 calcium malate Substances 0.000 description 2
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 description 2
- 229940016114 calcium malate Drugs 0.000 description 2
- 235000011038 calcium malates Nutrition 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 229920001429 chelating resin Polymers 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 241001446247 uncultured actinomycete Species 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- TVZRAEYQIKYCPH-UHFFFAOYSA-N 3-(trimethylsilyl)propane-1-sulfonic acid Chemical compound C[Si](C)(C)CCCS(O)(=O)=O TVZRAEYQIKYCPH-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001495437 Dactylosporangium Species 0.000 description 1
- 241000218946 Dactylosporangium thailandense Species 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241001134635 Micromonosporaceae Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000002814 agar dilution Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 239000006877 oatmeal agar Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000019086 sulfide ion homeostasis Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
- C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
- C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
- C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
- C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
- C07H15/236—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2 a saccharide radical being substituted by an alkylamino radical in position 3 and by two substituents different from hydrogen in position 4, e.g. gentamicin complex, sisomicin, verdamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/46—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin
- C12P19/48—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin the cyclohexyl radical being substituted by two or more nitrogen atoms, e.g. destomycin, neamin
- C12P19/485—Having two saccharide radicals bound through only oxygen to non-adjacent ring carbons of the cyclohexyl radical, e.g. gentamycin, kanamycin, sisomycin, verdamycin, mutamycin, tobramycin, nebramycin, antibiotics 66-40B, 66-40D, XK-62-2, 66-40, G-418, G-52
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明は、ダクチロスポランジウム属に属する
アミノ糖抗生物質G―367―1生産菌による新規
アミノ糖抗生物質G―367―1およびその製造法
に関する。
本発明の新規アミノ糖抗生物質G―367―1
(以下、G―367―1という)の理化学的性質は次
の通りである。
融 点:130〜133℃
〔α〕24 D:+188.9゜(C=1.0 H2O)
元素分析
実測値 理論値
C=50.14 C=50.51
H= 7.60 H= 7.84
N=14.42 N=14.73
分子量:475(マススペクトルより)
分子式:C20H37N5O8
紫外部吸収スペクトル:水溶液にて220〜
360nmに特徴的な極大吸収を示さず、末端吸収を
示すのみである。
赤外部吸収スペクトル:(KBr法)第1図に示
す通りであつて、3350、2920、1660、1590、
1380、1140、1100、1050、1000、950−1cm付近の各
波長に吸収帯を有す。
核磁気共鳴スペクトル(水素核):第2図に示
す通り(D2O中、100MHz、内部基準DSS)
核磁気共鳴スペクトル(炭素核):D2O中、
25MHzにて、ジオキサンを内部基準として測定し
た。
The present invention relates to a novel amino sugar antibiotic G-367-1 produced by an amino sugar antibiotic G-367-1 producing bacterium belonging to the genus Dactyrosporandium and a method for producing the same. Novel amino sugar antibiotic G-367-1 of the present invention
The physical and chemical properties of (hereinafter referred to as G-367-1) are as follows. Melting point: 130-133°C [α] 24 D : +188.9° (C = 1.0 H 2 O) Elemental analysis Actual value Theoretical value C = 50.14 C = 50.51 H = 7.60 H = 7.84 N = 14.42 N = 14.73 Molecular weight : 475 (from mass spectrum) Molecular formula: C 20 H 37 N 5 O 8 Ultraviolet absorption spectrum: 220 ~ in aqueous solution
It does not show the characteristic maximum absorption at 360 nm, but only shows terminal absorption. Infrared absorption spectrum: (KBr method) As shown in Figure 1, 3350, 2920, 1660, 1590,
It has absorption bands at wavelengths around 1380, 1140, 1100, 1050, 1000, and 950 -1 cm. Nuclear magnetic resonance spectrum (hydrogen nuclei): As shown in Figure 2 (in D 2 O, 100 MHz, internal reference DSS) Nuclear magnetic resonance spectrum (carbon nuclei): in D 2 O,
Measurements were made at 25MHz using dioxane as an internal reference.
【表】
溶解性:水、メタノールに可溶、アセトン、ベ
ンゼン、酢酸エチル、クロロホルムに不溶。
呈色反応:ニンヒドリン反応、過マンガン酸カ
リウム脱色反応は陽性、エルソンモルガン反応、
ビウレツト反応は陰性。
色性状:白色粉末。
酸塩基の区別:塩基性、
薄層クロマトグラフイー(シリカゲル)
水(1:1:1)の下層 Rf=0.36
10%酢酸アンモニウム:メタノール(1:1)
Rf=0.13
上記の理化学性状より、G―367―1は新規な
アミノ糖化合物と認められ、またその平面構造と
しては下記の構造が推定される新規化合物であ
る。
また、本発明のG―367―1の寒天希釈法によ
る抗菌スペクトル(最小発育阻止濃度を示す)は
次表の通りである。[Table] Solubility: Soluble in water and methanol, insoluble in acetone, benzene, ethyl acetate, and chloroform. Color reaction: ninhydrin reaction, potassium permanganate decolorization reaction positive, Elson Morgan reaction,
Biuretz reaction was negative. Color properties: white powder. Distinction between acids and bases: Basic, thin layer chromatography (silica gel) Lower layer of water (1:1:1) Rf = 0.36 10% ammonium acetate: methanol (1:1) Rf = 0.13 From the above physical and chemical properties, G -367-1 is recognized as a novel amino sugar compound, and its planar structure is predicted to be as shown below. Further, the antibacterial spectrum (indicating the minimum inhibitory concentration) of G-367-1 of the present invention obtained by the agar dilution method is shown in the following table.
【表】【table】
【表】
さらに本発明の抗菌性、特にグラム陰性菌に付
する優れた抗菌性を有するG―367―1は、通常
医薬的に許容される鉱散や有機酸などの無毒性酸
付加塩の形で使用でき、例えば塩酸、ヨウ化水素
酸、硫酸、リン酸、炭酸、酢酸、フマル酸、リン
ゴ酸、クエン酸、マンデル酸、コハク酸、アスコ
ルビン酸、アスパラギン酸、グルタミン酸などの
酸類との塩の形で使用できる。また本発明のG―
367―1またはその無毒性酸付加塩は、例えば20
〜40mg用バイアルまたは20〜40mg含有アンプルと
して注射用製剤として適用される。
本発明のG―367―1生産放線菌は、静岡県富
士市の畑土壌より分離した放線菌G―367であつ
て、ダクチロスポランジウム
(Dactylosporangium)属に属するダクチロスポ
ランジウム・タイランデンセG367
(Dactylosporagiumthailandense G 367)と同
定、命名した(微生物受託番号通知書微生物受託
番号「微工研菌寄第4840号FERM―P No.
4840)。
以下にその菌学的諸性状について述べる。
〔〕 形態的性状
リンゴ酸カルシウム寒天培地〔Bact.Rev.21:
1(1957)〕上、30℃、3―7日間培養し、観察
した所見は次の通りである。
基生菌糸は曲線状または屈曲状で、分枝をなし
て伸長し、分断はせず、直径0.5〜0.8μであり、
気菌糸は形成しない。
基性菌糸に、大きさ1.5〜2.0×2.0〜2.5μの球
状または楕円状物体の着生が、寒天培地中に埋つ
た状態でみられる。
基生菌糸より短かい胞子のう柄を生じ、胞子の
うは指形で、寒天培地表面上に、1個または房状
に形成する。胞子のうの大きさは、1.0〜1.5×4.0
〜6.5μで、中に3〜4個の胞子がたてに一列に
入つている。
胞子は水中で運動性があり、形は球形、楕円形
または洋梨形を呈し、大きさは1.0〜1.5×1.5〜
2.5μであり、極性で房状の鞭毛を有している。
〔〕 ジアミノピメリン酸組成
全菌体分析によるジアミノピメリン酸は、メゾ
―型およびメゾ―型よりRm値の低いもの(slow
moving diaminopimellic acid)が検出された。
〔〕 各種培地における生育状態等
各種培地上で、30℃、14日間培養し、観察した
所見は次表の通りであり、オート・ミール寒天培
地上で末発育の気菌糸がわずかに形成される以外
は、気菌糸の形成は認められず、また胞子のうは
リンゴ酸カルシウム寒天培地上で良好、土壌寒天
培地〔J.gen.Microbiol.50:295(1968)〕上で、
中程度であり、その他の培地上ではわずか、また
はほとんど形成されなかつた。
なお、色の表示は、カラー・ハーモニー・マニ
アル(color Harmony Manual)第4版1958年
(container Corporation of America)による色
の分類に従つたものである。[Table] Furthermore, G-367-1, which has antibacterial properties of the present invention, particularly has excellent antibacterial properties against Gram-negative bacteria, can be used in combination with non-toxic acid addition salts such as pharmaceutically acceptable mineral salts and organic acids. salts with acids such as hydrochloric acid, hydroiodic acid, sulfuric acid, phosphoric acid, carbonic acid, acetic acid, fumaric acid, malic acid, citric acid, mandelic acid, succinic acid, ascorbic acid, aspartic acid, glutamic acid, etc. It can be used in the form of Also, the G-
367-1 or its non-toxic acid addition salt, for example 20
Applied as an injectable formulation in vials for ~40 mg or ampoules containing 20-40 mg. The G-367-1-producing actinomycete of the present invention is an actinomycete G-367 isolated from field soil in Fuji City, Shizuoka Prefecture, and is Dactylosporangium thailandense G367, which belongs to the genus Dactylosporangium.
(Dactylosporagiumthailandense G 367) was identified and named (Microorganism Accession Number Notification Microorganism Accession Number "FERM-P No. 4840 FERM-P No.
4840). The mycological properties are described below. [] Morphological properties Calcium malate agar medium [Bact.Rev.21:
1 (1957)], and the following findings were observed after culturing at 30°C for 3-7 days. The basal hyphae are curved or bent, branched and elongated, undivided, and 0.5 to 0.8 μ in diameter.
Aerial mycelium does not form. Spherical or ellipsoidal objects measuring 1.5 to 2.0 x 2.0 to 2.5 microns are observed on the basal hyphae, buried in the agar medium. It produces sporangial stalks that are shorter than the basal hyphae, and the sporangia are finger-shaped and are formed singly or in clusters on the surface of the agar medium. The size of the sporangium is 1.0 to 1.5 x 4.0
~6.5μ, with 3-4 spores arranged vertically in a row. The spores are motile in water and are spherical, oval, or pear-shaped, and the size is 1.0-1.5 x 1.5-
It is 2.5μ in length and has a polar, tufted flagellum. [] Diaminopimelic acid composition Diaminopimelic acid determined by whole bacterial cell analysis is meso-type and meso-type with a lower Rm value (slow
moving diaminopimellic acid) was detected. [] Growth status on various media, etc. Cultured on various media at 30℃ for 14 days, and observed findings are as shown in the table below.On oatmeal agar medium, a few terminally growing aerial mycelia are formed. No formation of aerial mycelium was observed, and sporangia were good on calcium malate agar, and on soil agar [J.gen.Microbiol.50:295 (1968)].
It was moderate, and little or no formation occurred on other media. Note that the color display is based on the color classification according to the Color Harmony Manual, 4th edition, 1958 (Container Corporation of America).
【表】【table】
【表】 〔〕 生理的性状 生理的諸性状は下記の通りである。 1 炭素源の資化性【table】 [] Physiological properties Physiological properties are as follows. 1 Assimilation of carbon sources
【表】【table】
【表】
2 生育温度範囲:20〜40℃
3 脱脂牛乳:ペプトン化および凝固とともに陽
性
4 メラニン様色素の生成:陰性(チロシンおよ
びペプトン・イーストエキス・鉄寒天培地上)
5 スターチの加水分解:陽性
6 セルロースの分解:陰性
7 カゼインの分解:陽性
8 チロシンの分解:陰性
9 ゼラチンの液化:陽性
10 硫化水素の生成:弱い陽性
11 硝酸塩の還元:陽性
12 生育PH:PH5.5〜9.0
上記の通り、本菌G367の特徴としては、基生
菌糸に指形の胞子のうを着生し、胞子のう中に胞
子がたてに一列にならび、胞子に房状の鞭毛を有
していることにある。
このように、胞子のうを形成し、その中に鞭毛
を有する胞子を形成するものは、アクチノプラナ
セア(Actinoplanaceae)に属するものであつ
て、胞子のうが指形で、その中にたてに一列に胞
子が形成されるものは、ダクチロスポランジウム
属に属する。
さらに、本菌G367は有機培地上で、基生菌糸
が橙褐色ないし褐色を呈し、褐色の可溶性色素を
生ずる特徴を有することにより、ダクチロスポラ
ンジウム・タイランデンセ(Dactylosporangium
thailandense)〔Arch.Microbio1.58:42―52
(1967)〕に属するものと同定した。
よつて、本菌G367を、ダクチロスポランジウ
ム・タイランデンセG367と命名したものであ
る。
次いで、本発明の新規抗生物質たるG―367―
1を製造するに当つて例示すれば、上記のダクチ
ロスポランジウム属に属するG―367―1生産菌
を通常の微生物の培養に使用する培地成分を含む
培地にて好気的に培養することによつて得られ
る。培地としては、固型培地または液体培地が用
いられるが、特に大量生産のためには液体培地、
特に水性培地が適当である。
培地の栄養源としては、微生物の培養に通常用
いられるものが広く使用され得る。炭素源として
は同化可能な炭素化合物であればよく、例えばグ
ルコース、シユクロース、マルトース、スター
チ、デキストリン、モラツセなどが使用される。
窒素源としては利用可能な窒素化合物であればよ
く、例えばコーン・スチーブ・リカー、大豆粉、
綿実粉、小麦グルテン、ペプトン、肉エキス、酵
母エキス、カゼイン加水分解物、アンモニウム
塩、硝酸塩などが使用される。その他、リン酸
塩、マグネシウム、カルシウム、カリウム、ナト
リウム、コバルト、鉄、マンガンなどの塩類が必
要に応じて使用される。
培養温度は菌が発育し、G―367―1を生産す
る範囲内で適宜変更し得るが、特に好ましくは25
〜35℃である。培養時間は、条件によつて多少異
なるが、通常1100〜200時間程度であつて、G367
―1が最高力価に達する時期を見計つて適当な時
期に培養を終了すればよい。
このようにして得られたG―367―1生産菌の
液体培養の培養物中において、G―367―1は液
体部分に大部分産生されている。
次いでこのG―367―1生産菌の培養物からG
―367―1を採取するのであるかが、G―367―1
は水溶性の塩基性アミノ糖化合物であることを利
用して分離精製を行なうことが簡便である。また
生産されたG―367―1はバチルス・ズブチリス
PCI219を被検菌として、通常の寒天平板法によ
り活性区分の確認、および定量を行なつたもので
ある。
G―367―1の分離精製手段の一例を示すと次
の通りである。すなわちG―367―1生産菌を前
述の如く培養して得られる培養物から固形分を除
去して培養液を得るのであるが、G―367―1
がアミノ糖化合物であるためにその培養物のPHを
一旦酸性に調整し、これを中和して過してその
培養液を得ることが好ましく、次いでこの培養
液を陽イオン交換樹脂例えばアンバーライト
IRC―50(NH4 +型)のカラムにチヤージせしめ
て吸着せしめ、これより活性物質を2Nアンモニ
ア水にて溶出せしめ、さらにその溶出液を濃縮し
た後、そのPHを調整し、陽イオン交換樹脂例えば
CM―セフアデツクスC―25(NH4 +型)のカラム
にチヤージせしめて吸着せしめ、0〜0.35Nの濃
度勾配をもたせたアンモニア水にて溶出せしめ、
その活性画分を得、これを減圧濃縮し、凍結乾燥
することによりG―367―1の精製白色粉末を遊
離塩基の型にて得られる。またこの様にして得ら
れるG―367―1は薄層クロマトグラフイーにて
単一スポツトを示すものであることが簡便になし
得る。
次に本発明の実施例を挙げて具体的に説明する
が、本発明はこれにより何んら限定されるもので
はない。
実施例 1
デキストリン1%、グルコース1%、カゼイン
水解物0.5%、酵母エキス0.5%、炭酸カルシウム
0.1%を含有する培地(PH7.0)100mlを500ml容三
角フラスコに分取し、120℃、20分間加熱殺菌し
た。本培地10本に、各々ダクチロスポランジウ
ム・タイランデンセG367株の斜面培養物よりの
一白金耳を接種し、30℃、120時間振盪培養し
た。次いでこれを上記と同一組成の加熱殺菌した
培地20を含有する30容ジヤーフアーメンター
に移植し、30℃、72時間、300rpm、毎分20の
無菌空気の条件下で通気撹拌培養した。次いでデ
キストリン5%、グルコース0.5%、脱脂大豆粉
3%、炭酸カルシウム0.7%、塩化コバルト
1.3ppmを含有する加熱殺菌した培地(PH7.2)
200を含有する250容タンクに上記の培養物10
を移植し、30℃、120時間、250rpm、毎分100
の無菌空気の条件下通気撹拌培養し、培養物約
190を得た。
次いで、実施例2の如くして、その培養物より
G―367―1を分離精製するものである。
実施例 2
実施例1で得られた培養物を、12N硫酸水溶液
にてPH2に調整し、30分間撹拌した後、濃アンモ
ニア水にてPH7.0に調整し、さらにこれに過助
剤としてパーライト(商品名)4Kgを加えて過
し、次いで得られた培養液を、アンバーライト
IRC―50(ローム・アンド・ハース社製)NH4 +
型)10を充填したカラムにチヤージし、水洗し
た後、2Nアンモニア水20にて溶出せしめ、そ
の全溶出液を得、これを100mlまで減圧濃縮し
た。
次いでこの濃縮液を6N硫酸水溶液にてPH7.0に
調整し、これを、CM―セフアデツクスG―25
(フアルマシア・フアイン・ケミカル社製)
(NH4 +型)500mlを充填したカラム(径4cm)に
チヤージして活性物質を吸着せしめた。その後該
カラムを水洗後、0〜0.35Nの濃度勾配をもたせ
たアンモニア水5により溶出せしめ、溶出液を
20mlずつ分画した。各分画について、クロロホル
ム:メタノール:28%アンモニア水=1:1:1
の下層を展開溶媒とした薄層クロマトグラフイー
を行ない、ニンヒドリン発色により目的物を確認
した。その結果、第175画分より185画分がG―
367―1のみを含有したものであつた。次いでこ
の画分を回収、合せて減圧濃縮し、次いで凍結乾
燥して、白色粉末を得、さらにこれを、五酸化リ
ンの存在下で40℃、48時間減圧乾燥して、G―
367―1の精製白色粉末(遊離塩基)750mgを得
た。[Table] 2 Growth temperature range: 20-40℃ 3 Skim milk: Positive with peptonization and coagulation 4 Production of melanin-like pigment: Negative (on tyrosine and peptone yeast extract iron agar medium) 5 Hydrolysis of starch: Positive 6 Cellulose decomposition: Negative 7 Casein decomposition: Positive 8 Tyrosine decomposition: Negative 9 Gelatin liquefaction: Positive 10 Hydrogen sulfide generation: Weak positive 11 Nitrate reduction: Positive 12 Growth pH: PH5.5-9.0 As above The characteristics of this fungus G367 are that it grows finger-shaped sporangia on the basal hyphae, the spores are arranged vertically in a single row, and the spores have tufted flagella. It is in. In this way, spores that form sporangia and have flagella inside them belong to the family of Actinoplanaceae, and the sporangium is finger-shaped and there are upright spores inside. Those in which spores are formed in a row belong to the genus Dactyrosporandium. Furthermore, this fungus G367 has the characteristic that the basal hyphae exhibit an orange-brown to brown color and produce a brown soluble pigment on an organic medium.
thailandense) [Arch.Microbio1.58:42-52
(1967)]. Therefore, this bacterium G367 was named Dactyrosporandium thailandense G367. Next, G-367-, the novel antibiotic of the present invention
For example, in producing 1, the G-367-1 producing bacteria belonging to the genus Dactylosporandium is aerobically cultured in a medium containing medium components used for the cultivation of ordinary microorganisms. obtained by. As a medium, a solid medium or a liquid medium is used, but especially for mass production, a liquid medium,
Particularly suitable are aqueous media. As the nutrient source for the medium, a wide variety of nutrients commonly used for culturing microorganisms can be used. The carbon source may be any assimilable carbon compound, such as glucose, sucrose, maltose, starch, dextrin, and molasses.
As a nitrogen source, any available nitrogen compound may be used, such as corn stew liquor, soybean flour,
Cottonseed flour, wheat gluten, peptone, meat extract, yeast extract, casein hydrolyzate, ammonium salts, nitrates, etc. are used. In addition, salts such as phosphate, magnesium, calcium, potassium, sodium, cobalt, iron, and manganese are used as necessary. The culture temperature can be changed as appropriate within the range that allows the bacteria to grow and produce G-367-1, but is particularly preferably 25
~35℃. The culture time varies slightly depending on the conditions, but is usually about 1100 to 200 hours.
-1 should reach its maximum titer and then terminate the culture at an appropriate time. In the liquid culture of the G-367-1 producing bacteria thus obtained, G-367-1 is mostly produced in the liquid portion. Next, from the culture of this G-367-1 producing bacteria, G
-367-1 is collected, but G-367-1
It is easy to separate and purify the compound by taking advantage of the fact that it is a water-soluble basic amino sugar compound. Also produced G-367-1 is Bacillus subtilis
Using PCI219 as the test bacterium, the active category was confirmed and quantified using the usual agar plate method. An example of separation and purification means for G-367-1 is as follows. That is, the solid content is removed from the culture obtained by culturing G-367-1 producing bacteria as described above to obtain a culture solution.
is an amino sugar compound, it is preferable to first adjust the pH of the culture to acidic and neutralize it to obtain a culture solution.Then, this culture solution is treated with a cation exchange resin such as Amberlite.
The active substance was charged and adsorbed onto an IRC-50 (NH 4 + type) column, from which the active substance was eluted with 2N ammonia water, the eluate was further concentrated, the pH was adjusted, and the active substance was added to a cation exchange resin. for example
Charge and adsorb onto a column of CM-Sephadex C-25 (NH 4 + type), elute with aqueous ammonia with a concentration gradient of 0 to 0.35N,
The active fraction is obtained, concentrated under reduced pressure, and lyophilized to obtain a purified white powder of G-367-1 in the form of a free base. Furthermore, G-367-1 obtained in this manner can easily be found to show a single spot in thin layer chromatography. Next, the present invention will be specifically explained with reference to Examples, but the present invention is not limited thereto in any way. Example 1 Dextrin 1%, glucose 1%, casein hydrolyzate 0.5%, yeast extract 0.5%, calcium carbonate
100 ml of a medium containing 0.1% (PH7.0) was dispensed into a 500 ml Erlenmeyer flask and sterilized by heating at 120°C for 20 minutes. One platinum loop from a slant culture of Dactyrosporandium thailandense strain G367 was inoculated into 10 bottles of this medium, and cultured with shaking at 30°C for 120 hours. This was then transferred to a 30-volume jar fermenter containing heat-sterilized medium 20 having the same composition as above, and cultured with aeration at 30°C for 72 hours under conditions of 300 rpm and sterile air at 20 per minute. Next, 5% dextrin, 0.5% glucose, 3% defatted soy flour, 0.7% calcium carbonate, and cobalt chloride.
Heat-sterilized medium containing 1.3ppm (PH7.2)
Culture 10 of the above into a 250 volume tank containing 200
transplanted, 30℃, 120 hours, 250 rpm, 100 rpm
Culture with aeration and agitation under sterile air conditions, and culture approx.
Got 190. Next, as in Example 2, G-367-1 was isolated and purified from the culture. Example 2 The culture obtained in Example 1 was adjusted to pH 2 with a 12N sulfuric acid aqueous solution, stirred for 30 minutes, adjusted to pH 7.0 with concentrated ammonia water, and further added with perlite as a super-aid. (Product name) 4Kg was added and filtered, and then the resulting culture solution was mixed with Amberlite.
IRC-50 (Rohm & Haas) NH 4 +
The column was charged to a column packed with Type) 10, washed with water, and eluted with 2N ammonia water 20 to obtain the entire eluate, which was concentrated under reduced pressure to 100 ml. Next, this concentrated solution was adjusted to pH 7.0 with 6N sulfuric acid aqueous solution, and then added to CM-Sephadex G-25.
(Manufactured by Pharmacia Huain Chemical Co.)
A column (diameter 4 cm) packed with 500 ml (NH 4 + form) was charged to adsorb the active substance. After washing the column with water, the column was eluted with aqueous ammonia 5 with a concentration gradient of 0 to 0.35N, and the eluate was
It was fractionated into 20 ml portions. For each fraction, chloroform: methanol: 28% ammonia water = 1:1:1
Thin layer chromatography was performed using the lower layer as a developing solvent, and the target product was confirmed by ninhydrin color development. As a result, the 185th fraction from the 175th fraction was G-
It contained only 367-1. The fractions were then collected, combined, concentrated under reduced pressure, and then lyophilized to obtain a white powder, which was further dried under reduced pressure at 40°C for 48 hours in the presence of phosphorus pentoxide to obtain G-
750 mg of purified white powder (free base) of 367-1 was obtained.
第1図は本発明のG―367―1の赤外部吸収ス
ペクトル、第2図は本発明のG―367―1の核磁
気共鳴スペクトル(水素核)を示す。
FIG. 1 shows the infrared absorption spectrum of G-367-1 of the present invention, and FIG. 2 shows the nuclear magnetic resonance spectrum (hydrogen nuclei) of G-367-1 of the present invention.
Claims (1)
生物質G―367―1とその無毒性酸付加塩 融点 130〜133℃ 〔α〕24 D+188.9゜(C=1.0 H2O) 元素分析 実測値 理論値 C=50.14 C=50.51 H= 7.60 H= 7.84 N=14.42 N=14.73 分子量 475(マススペクトルより) 分子式 C20H37N5O8 紫外部吸収スペクトル 220〜360nmに特徴的
な極大吸収を示さず、未端吸収を示すのみであ
る 赤外部吸収スペクトル (KBr法) 3350,2920,1660,1590,1380,1140,
1100,1050,1000,950cm-1付近の各波長に
吸収帯を有す。 溶解性 水、メタノールに可溶、アセトン、ベ
ンゼン、酢酸エチル、クロロホルムに不溶、 呈色反応 ニンヒドリン反応、過マンガン酸カ
リウム脱色反応は陽性、エルソンモルガン反
応、ビウレツト反応は陰性。 色性状 白色 酸塩基の区別 塩基性 2 ダクチロスポランジウム属に属するアミノ糖
抗生物質G―367―1生産菌を培地に培養し、そ
の培養物より抗生物質G―367―1を採取するこ
とを特徴とする抗生物質G―367―1の製造法。[Scope of Claims] 1 Amino sugar antibiotic G-367-1 and its non-toxic acid addition salt having the following physical and chemical properties Melting point 130-133°C [α] 24 D +188.9° (C= 1.0 H 2 O) Elemental analysis Actual measurement Theoretical value C = 50.14 C = 50.51 H = 7.60 H = 7.84 N = 14.42 N = 14.73 Molecular weight 475 (from mass spectrum) Molecular formula C 20 H 37 N 5 O 8 Ultraviolet absorption spectrum 220 It does not show the characteristic maximum absorption at ~360 nm, and only shows edge absorption. Infrared absorption spectrum (KBr method) 3350, 2920, 1660, 1590, 1380, 1140,
It has absorption bands at each wavelength around 1100, 1050, 1000, and 950 cm -1 . Solubility: Soluble in water and methanol, insoluble in acetone, benzene, ethyl acetate, and chloroform; Color reaction: Positive for ninhydrin reaction and potassium permanganate decolorization reaction; negative for Elson-Morgan reaction and Biuret reaction. Color property: White Acid-base distinction: Basic 2 The amino sugar antibiotic G-367-1 producing bacteria belonging to the genus Dactyrosporandium is cultured in a medium, and the antibiotic G-367-1 is collected from the culture. Characteristic method for producing antibiotic G-367-1.
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4127479A JPS55133394A (en) | 1979-04-04 | 1979-04-04 | Novel aminosaccharide antibiotic g-367-1 and its preparation |
CA000349243A CA1140877A (en) | 1979-04-04 | 1980-04-03 | Aminoglycoside antibiotics and production thereof |
GB8011265A GB2053895B (en) | 1979-04-04 | 1980-04-03 | Aminoglycoside antibiotics and their production |
US06/137,292 US4297486A (en) | 1979-04-04 | 1980-04-03 | Aminoglycoside antibiotic G-367-1 and method for the production thereof |
FR8007574A FR2452932A1 (en) | 1979-04-04 | 1980-04-03 | NOVEL AMINOGLYCOSIDE ANTIBIOTICS AND THEIR PRODUCTION |
DE19803013210 DE3013210A1 (en) | 1979-04-04 | 1980-04-03 | NEW AMINOGLYCOSIDE ANTIBIOTICS AND METHOD FOR THEIR PRODUCTION |
CH5618/80A CH648855A5 (en) | 1979-04-04 | 1980-07-23 | Aminoglycoside antibiotics and process for their preparation |
BE0/201867A BE884925A (en) | 1979-04-04 | 1980-08-26 | NOVEL AMINOGLYCOSIDE ANTIBIOTIC AND METHOD FOR THE PRODUCTION THEREOF. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4127479A JPS55133394A (en) | 1979-04-04 | 1979-04-04 | Novel aminosaccharide antibiotic g-367-1 and its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS55133394A JPS55133394A (en) | 1980-10-17 |
JPS6126914B2 true JPS6126914B2 (en) | 1986-06-23 |
Family
ID=12603856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4127479A Granted JPS55133394A (en) | 1979-04-04 | 1979-04-04 | Novel aminosaccharide antibiotic g-367-1 and its preparation |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS55133394A (en) |
BE (1) | BE884925A (en) |
CH (1) | CH648855A5 (en) |
DE (1) | DE3013210A1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3907771A (en) * | 1971-02-03 | 1975-09-23 | Schering Corp | Antibiotic 66-40 |
US3920628A (en) * | 1972-10-24 | 1975-11-18 | Schering Corp | 2{41 -Deoxyaminoglycosides and 2{41 -epi-amino-3{41 -desamino derivatives thereof, methods for their manufacture and novel intermediates useful therein |
EP0000473B1 (en) * | 1977-06-24 | 1981-03-11 | Scherico Ltd. | Process for preparing aminoglycoside derivatives, novel derivatives obtained and pharmaceutical compositions containing such derivatives |
-
1979
- 1979-04-04 JP JP4127479A patent/JPS55133394A/en active Granted
-
1980
- 1980-04-03 DE DE19803013210 patent/DE3013210A1/en not_active Ceased
- 1980-07-23 CH CH5618/80A patent/CH648855A5/en not_active IP Right Cessation
- 1980-08-26 BE BE0/201867A patent/BE884925A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE3013210A1 (en) | 1980-11-20 |
CH648855A5 (en) | 1985-04-15 |
BE884925A (en) | 1980-12-16 |
JPS55133394A (en) | 1980-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0182315B1 (en) | Novel antibiotic nk84-0218 pharmaceutical compositions containing it and process for the production of the same | |
JPS6317078B2 (en) | ||
JPS6041491A (en) | New antibiotic | |
US3987029A (en) | Antibacterial antibiotics AM31α, AM31β and AM31γ | |
JPS6331477B2 (en) | ||
JPS6126914B2 (en) | ||
JPS6069085A (en) | Difficidin and derivative antibacterial substance | |
JPS6122955B2 (en) | ||
USRE29903E (en) | Antibacterial antibiotics AM31α, AM31β and AM31γ | |
SU539538A3 (en) | Method for producing metabolite 2776 | |
US3974035A (en) | Process for preparing a cephamycin type antibiotic substance | |
JPH0153675B2 (en) | ||
JPS6123996B2 (en) | ||
JPS6212227B2 (en) | ||
US3734832A (en) | Fermentation process for producing physostigmine | |
JPH0153676B2 (en) | ||
KR830000617B1 (en) | Process for preparing antibiotics sf 2050 substances | |
JPS6130558B2 (en) | ||
JPS6212228B2 (en) | ||
JPS6348284A (en) | Novel antibiotic yp-02908l-a and production thereof | |
JPH0341089A (en) | Physiologically active substance 3127 | |
JPH06312997A (en) | Ko-8119 substance and its production | |
JPS58111687A (en) | Preparation of antibiotic fortimicin a or b | |
JPS63192792A (en) | Novel antibiotic sf 2487 substance and production thereof | |
JPS6250474B2 (en) |